Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
about
Randomized Controlled Trials of Add-On Antidepressants in SchizophreniaMeta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophreniaWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.Role of mirtazapine in the treatment of antipsychotic-induced akathisia.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Mirtazapine: a review of its clinical efficacy and tolerability.The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?Adjunct mirtazapine for negative symptoms of schizophrenia.α2-Adrenoceptors are targets for antipsychotic drugs.Mirtazapine: only for depression?The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review.Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.Schizophrenia trials conducted in African countries: a drop of evidence in the ocean of morbidity?Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase.The Black Book of Psychotropic Dosing and Monitoring.Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics.Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence.Substantial increase in number and dosage of antipsychotics in non-responsive vs. responsive schizophrenia inpatients.Remission of mood disorder with psychotic features after treatment with mirtazapine.Anticholinergic discontinuation and cognitive functions in patients with schizophrenia: a pharmacist–physician collaboration in the outpatient department
P2860
Q28080437-D872A648-EB34-4023-BDBE-725930CD24DAQ28248687-87921DB6-F625-470F-BD8C-06F1DFC46BEEQ33223628-2BE862F1-EECD-43E6-91F8-8969390C355AQ33235110-5E1A45A8-082B-4565-81E7-E7416B183F21Q34011540-4F440696-0E93-4231-B18F-0AE5AB158F14Q34640811-EFA7E037-4A7E-4C8B-A6ED-62FDA642A9FAQ36150725-781073DA-731F-478A-8225-30E4CE4FF00BQ37685759-3BDC0EEA-FD5C-404B-B696-727B64D6A240Q37939248-8E4DECCE-A660-4A12-8D55-CBD3801DC45EQ38184439-D843DFC8-93E0-4315-B160-842216C189A0Q38779530-8326ADDA-FB39-44DA-9E3B-C63A589D781EQ38861612-0C6C0F4C-DCC8-42F4-9EAE-0A298122B817Q38916126-674BC1DA-7A3D-4FB5-AD02-CF72BB865ADFQ42326625-58A65CD9-51DE-4562-9C46-43F56462B5B2Q43672729-0FE0FC59-1728-42B7-9A06-FC1E77C571D4Q47642128-CA7C4075-E62A-450D-B7A1-D9712F2FF0F7Q47922406-F32755A8-3B89-48EF-B944-BE3BC889E8F3Q48643283-556CC296-A821-494F-92A3-DA4C93F09C92Q50062569-A72E8804-F8DF-48CA-B158-A4B9CE49747DQ52025509-7FF2C5D3-51A3-489B-A8FC-623A8373B547Q53907126-7A1C2146-28EE-4A36-9BF8-9F1F964C0A66Q59126207-22BF2F09-B8A1-4D6B-9E6A-4B654BAB4937
P2860
Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Efficacy of mirtazapine add on ...... ized placebo-controlled study.
@ast
Efficacy of mirtazapine add on ...... ized placebo-controlled study.
@en
type
label
Efficacy of mirtazapine add on ...... ized placebo-controlled study.
@ast
Efficacy of mirtazapine add on ...... ized placebo-controlled study.
@en
prefLabel
Efficacy of mirtazapine add on ...... ized placebo-controlled study.
@ast
Efficacy of mirtazapine add on ...... ized placebo-controlled study.
@en
P1476
Efficacy of mirtazapine add on ...... mized placebo-controlled study
@en
P356
10.1097/00004850-200103000-00003
P50
P577
2001-03-01T00:00:00Z